{
    "clinical_study": {
        "@rank": "105694", 
        "arm_group": {
            "arm_group_label": "OnabotulinumtoxinA", 
            "description": "OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice."
        }, 
        "brief_summary": {
            "textblock": "This is an observational study to assess health-related quality of life in patients with\n      cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice."
        }, 
        "brief_title": "A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA", 
        "completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Torticollis", 
        "condition_browse": {
            "mesh_term": "Torticollis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of cervical dystonia (dystonie) and able to receive botulinum toxin Type A\n             as deemed medically necessary by the physician\n\n        Exclusion Criteria:\n\n          -  Participation in a clinical trial for any botulinum toxin indication\n\n          -  Planning elective surgery during the observational study period\n\n          -  Treatment with any botulinum toxin product for cervical dystonia (dystonie)\n\n          -  Treatment with any botulinum toxin product for a non cervical dystonia (dystonie)\n             condition within 2 months of study start"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with Cervical Dystonia (Dystonie)"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01655862", 
            "org_study_id": "CMA-BTX-12-001"
        }, 
        "intervention": {
            "arm_group_label": "OnabotulinumtoxinA", 
            "description": "OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice.", 
            "intervention_name": "OnabotulinumtoxinA", 
            "intervention_type": "Biological", 
            "other_name": [
                "botulinum toxin Type A", 
                "BOTOX\u00ae"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "clinicaltrials@allergan.com", 
            "last_name": "Allergan Inc."
        }, 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline in Cervical Dystonia Impact Profile Questionnaire (CDIP-58) Score", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 96 Weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01655862"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patient's Global Impression of Change (PGIC) Using a 7-Point Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 96 Weeks"
            }, 
            {
                "measure": "Work Productivity Assessment Using a 10-Item Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "96 Weeks"
            }, 
            {
                "measure": "Change from Baseline in Hospital Anxiety and Depression Scale (HAD) Score", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 96 Weeks"
            }, 
            {
                "measure": "Reasons for Withdrawal of Treatment", 
                "safety_issue": "No", 
                "time_frame": "96 Weeks"
            }
        ], 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}